These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17012606)

  • 21. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.
    O'Neill MJ; Murray TK; Whalley K; Ward MA; Hicks CA; Woodhouse S; Osborne DJ; Skolnick P
    Eur J Pharmacol; 2004 Feb; 486(2):163-74. PubMed ID: 14975705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoradiographic visualization of group III metabotropic glutamate receptors using [3H]-L-2-amino-4-phosphonobutyrate.
    Hudtloff C; Thomsen C
    Br J Pharmacol; 1998 Jul; 124(5):971-7. PubMed ID: 9692783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression.
    Sadeghian M; Marinova-Mutafchieva L; Broom L; Davis JB; Virley D; Medhurst AD; Dexter DT
    J Neuroimmunol; 2012 May; 246(1-2):69-77. PubMed ID: 22498097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses.
    Agari T; Yasuhara T; Matsui T; Kuramoto S; Kondo A; Miyoshi Y; Shingo T; Borlongan CV; Date I
    Brain Res; 2008 Apr; 1203():189-96. PubMed ID: 18313647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons.
    Valenti O; Mannaioni G; Seabrook GR; Conn PJ; Marino MJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1296-304. PubMed ID: 15761115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation.
    Kearney JA; Becker JB; Frey KA; Albin RL
    Neuroscience; 1998 Dec; 87(4):881-91. PubMed ID: 9759976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological and behavioral effects of group III metabotropic glutamate receptors on pallidal neurons in normal and parkinsonian rats.
    Sun XR; Chen L; Chen WF; Xue Y; Yung WH
    Synapse; 2013 Dec; 67(12):831-8. PubMed ID: 23813476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective effects of group III mGluR in traumatic neuronal injury.
    Faden AI; Ivanova SA; Yakovlev AG; Mukhin AG
    J Neurotrauma; 1997 Dec; 14(12):885-95. PubMed ID: 9475370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Group III metabotropic glutamate receptor-mediated, chemically induced long-term depression differentially affects cell viability in the hippocampus.
    Naie K; Gundimi S; Siegmund H; Heinemann U; Manahan-Vaughan D
    Eur J Pharmacol; 2006 Mar; 535(1-3):104-13. PubMed ID: 16545366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
    Breit S; Lessmann L; Benazzouz A; Schulz JB
    Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echinacoside prevents the striatal extracellular levels of monoamine neurotransmitters from diminution in 6-hydroxydopamine lesion rats.
    Chen H; Jing FC; Li CL; Tu PF; Zheng QS; Wang ZH
    J Ethnopharmacol; 2007 Dec; 114(3):285-9. PubMed ID: 17951018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists.
    Sibille P; Lopez S; Brabet I; Valenti O; Oueslati N; Gaven F; Goudet C; Bertrand HO; Neyton J; Marino MJ; Amalric M; Pin JP; Acher FC
    J Med Chem; 2007 Jul; 50(15):3585-95. PubMed ID: 17602546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease.
    Cheng B; Yang X; An L; Gao B; Liu X; Liu S
    Brain Res; 2009 Aug; 1286():25-31. PubMed ID: 19559687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of glutamate transporters leads to potentiation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex via group II metabotropic glutamate receptor activation.
    Oliveira JF; Krügel U; Köles L; Illes P; Wirkner K
    Neuropharmacology; 2008 Sep; 55(4):447-53. PubMed ID: 18680754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.
    Breit S; Lessmann L; Unterbrink D; Popa RC; Gasser T; Schulz JB
    Eur J Neurosci; 2006 Oct; 24(8):2275-82. PubMed ID: 17042796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system.
    Venero JL; Romero-Ramos M; Revuelta M; Machado A; Cano J
    Brain Res; 1995 Feb; 672(1-2):153-8. PubMed ID: 7749737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
    Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group III metabotropic glutamate receptors act as hetero-receptors modulating evoked GABA release in the globus pallidus in vivo.
    Macinnes N; Duty S
    Eur J Pharmacol; 2008 Feb; 580(1-2):95-9. PubMed ID: 18035348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.